Marksans Pharma Limited: board meetings

62 records, the earliest from 27 Mar 2008. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

62 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DatePurposeNotes
12 Aug 2026Financial ResultsTo consider and approve the Unaudited Financial Results for the quarter ended Jun 30, 2026
26 May 2026Financial Results/DividendTo consider and approve Audited Standalone and Consolidated Financial Results and to consider recommendation of dividend if any, for the Financial Year ended March 31, 2026
5 Feb 2026Financial ResultsTo consider and approve the financial results for the quarter ended December 31, 2025
13 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
12 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
19 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend
11 Feb 2025Financial ResultsTo consider and approve the Unaudited financial results for the quarter and nine months ended December 31, 2024
12 Nov 2024Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024
13 Aug 2024Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2024
30 May 2024Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2024 and dividend

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.